ConductScience.org, home

Paper9847367

Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen.

Polacino P and 9 others. J Virol, 1999. Cited by 53 papers, by iCite.

Cite this record

ConductScience Library. Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen. Papers, record 9847367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9847367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen.
PubMed
Journal
J Virol
PubMed
Year
1999
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
1.08
iCite
Revised in PubMed
2020-07-24
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Polacino PP
2Stallard VV
3Klaniecki JEJ E
4Montefiori DCD C
5Langlois AJA J
6Richardson BAB A
7Overbaugh JJ
8Morton WRW R
9Benveniste RER E
10Hu SLS L

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SAIDS VaccinesMajor topic
Simian Acquired Immunodeficiency SyndromeMajor topic
Vaccines, SyntheticMajor topic
Viral Envelope ProteinsMajor topic
Amino Acid Sequence
Animals
Humans
Immunization
Macaca fascicularis
Macaca nemestrina
Molecular Sequence Data

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P51 RR000166NCRR NIH HHSUnited StatesP06RR000166PubMed and NIHNIH RePORTER
AI26503NIAID NIH HHSUnited StatesPubMedPubMed
AI65302NIAID NIH HHSUnited StatesN01AI065302PubMed and NIHNIH RePORTER
RR00166NCRR NIH HHSUnited StatesP06RR000166PubMed and NIHNIH RePORTER
P40RR000166NIHNIH RePORTER
P51RR000166NIHNIH RePORTER

Download CSV of grants

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17986589High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection.AIDS Res Hum Retroviruses1994https://conductscience.org/library/papers/7986589PubMed
22547964Molecular characterization and comparison of simian immunodeficiency virus isolates from macaques, mangabeys, and African green monkeys.J Med Primatol1989https://conductscience.org/library/papers/2547964PubMed
37707540Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus.J Virol1995https://conductscience.org/library/papers/7707540PubMed
47585061HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques.Nat Med1995https://conductscience.org/library/papers/7585061PubMed
58734355Progress and challenges toward an AIDS vaccine: Brother, can you spare a paradigm?J Clin Immunol1996https://conductscience.org/library/papers/8734355PubMed
68763998Detection of simian immunodeficiency virus (SIV)-specific CD8+ T cells in macaques protected from SIV challenge by prior SIV subunit vaccination.J Virol1996https://conductscience.org/library/papers/8763998PubMed
78818840Strategies for AIDS vaccines.J Antimicrob Chemother1996https://conductscience.org/library/papers/8818840PubMed
88605050Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2.AIDS1995https://conductscience.org/library/papers/8605050PubMed
98627721Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.J Virol1996https://conductscience.org/library/papers/8627721PubMed
108827214Multiple immunizations with attenuated poxvirus HIV type 2 recombinants and subunit boosts required for protection of rhesus macaques.AIDS Res Hum Retroviruses1996https://conductscience.org/library/papers/8827214PubMed
112550935Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2550935PubMed
122190095Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.Nature1990https://conductscience.org/library/papers/2190095PubMed
132231688Characterization of clones of HIV-1 infected HuT 78 cells defective in gag gene processing and of SIV clones producing large amounts of envelope glycoprotein.J Med Primatol1990https://conductscience.org/library/papers/2231688PubMed
141988952Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1988952PubMed
152045792Effects of mutations in glycosylation sites and disulphide bonds on processing, CD4-binding and fusion activity of human immunodeficiency virus envelope glycoproteins.J Gen Virol1991https://conductscience.org/library/papers/2045792PubMed
161815549Anti-cell antibody in macaques.Nature1991https://conductscience.org/library/papers/1815549PubMed
171718347In vitro assays for detecting neutralizing and fusion-inhibiting antibodies to SIVMAC251.AIDS Res Hum Retroviruses1991https://conductscience.org/library/papers/1718347PubMed
181942255Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS.J Virol1991https://conductscience.org/library/papers/1942255PubMed
191742074Cross-neutralizing antibodies in rabbits immunized with HIV-1 gp160 purified from simian cells infected with a recombinant vaccinia virus.AIDS Res Hum Retroviruses1991https://conductscience.org/library/papers/1742074PubMed
201531159Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.Science1992https://conductscience.org/library/papers/1531159PubMed

See all 55 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
26718849Oral Immunization with Recombinant Vaccinia Virus Prime and Intramuscular Protein Boost Provides Protection against Intrarectal Simian-Human Immunodeficiency Virus Challenge in Macaques.Clin Vaccine Immunol2015https://conductscience.org/library/papers/26718849PubMed
26424619Assembly and characterization of gp160-nanodiscs: A new platform for biochemical characterization of HIV envelope spikes.J Virol Methods2015https://conductscience.org/library/papers/26424619PubMed
22214267Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent Clade B virus-like particle vaccine.AIDS Res Hum Retroviruses2012https://conductscience.org/library/papers/22214267PubMed
21247355Recent insights into the mechanism and consequences of TRIM5α retroviral restriction.AIDS Res Hum Retroviruses2011https://conductscience.org/library/papers/21247355PubMed
20107597TRIM5alpha Modulates Immunodeficiency Virus Control in Rhesus Monkeys.PLoS Pathog2010https://conductscience.org/library/papers/20107597PubMed
19389453Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines.Vaccine2009https://conductscience.org/library/papers/19389453PubMed
19241253Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccine.Int Rev Immunol2009https://conductscience.org/library/papers/19241253PubMed
18980542Viral sequence diversity: challenges for AIDS vaccine designs.Expert Rev Vaccines2008https://conductscience.org/library/papers/18980542PubMed
17574643Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.Virology2007https://conductscience.org/library/papers/17574643PubMed
16763152Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.Science2006https://conductscience.org/library/papers/16763152PubMed
16051831Influence of glycosylation on the efficacy of an Env-based vaccine against simian immunodeficiency virus SIVmac239 in a macaque AIDS model.J Virol2005https://conductscience.org/library/papers/16051831PubMed
15975024Non-human primate models for AIDS vaccine research.Curr Drug Targets Infect Disord2005https://conductscience.org/library/papers/15975024PubMed
15220422Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.J Virol2004https://conductscience.org/library/papers/15220422PubMed
15140996Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies.J Virol2004https://conductscience.org/library/papers/15140996PubMed
11462016Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors.J Virol2001https://conductscience.org/library/papers/11462016PubMed
11000209Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus.J Virol2000https://conductscience.org/library/papers/11000209PubMed
10684264
Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge.
J Virol2000https://conductscience.org/library/papers/10684264PubMed
10482571Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques.J Virol1999https://conductscience.org/library/papers/10482571PubMed
10229229Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations.Nat Med1999https://conductscience.org/library/papers/10229229PubMed
10074165Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines.J Virol1999https://conductscience.org/library/papers/10074165PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ENPEP2028PubTator's text mininghttps://conductscience.org/library/genes/2028

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9847367

GET https://conductscience.org/api/papers/v1/9847367/references?page=2